Viveon Health Acquisition (VHAQ) Competitors $10.00 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends VHAQ vs. ZYBT, GOSS, CADL, MOLN, FULC, LRMR, FDMT, ACB, OCGN, and SOPHShould you be buying Viveon Health Acquisition stock or one of its competitors? The main competitors of Viveon Health Acquisition include Zhengye Biotechnology (ZYBT), Gossamer Bio (GOSS), Candel Therapeutics (CADL), Molecular Partners (MOLN), Fulcrum Therapeutics (FULC), Larimar Therapeutics (LRMR), 4D Molecular Therapeutics (FDMT), Aurora Cannabis (ACB), Ocugen (OCGN), and SOPHiA GENETICS (SOPH). These companies are all part of the "pharmaceutical products" industry. Viveon Health Acquisition vs. Zhengye Biotechnology Gossamer Bio Candel Therapeutics Molecular Partners Fulcrum Therapeutics Larimar Therapeutics 4D Molecular Therapeutics Aurora Cannabis Ocugen SOPHiA GENETICS Viveon Health Acquisition (NYSE:VHAQ) and Zhengye Biotechnology (NASDAQ:ZYBT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends. Which has stronger valuation and earnings, VHAQ or ZYBT? Zhengye Biotechnology has higher revenue and earnings than Viveon Health Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViveon Health AcquisitionN/AN/A-$610KN/AN/AZhengye Biotechnology$189.75M1.18N/AN/AN/A Is VHAQ or ZYBT more profitable? Company Net Margins Return on Equity Return on Assets Viveon Health AcquisitionN/A N/A N/A Zhengye Biotechnology N/A N/A N/A Do insiders & institutionals believe in VHAQ or ZYBT? 22.1% of Viveon Health Acquisition shares are owned by institutional investors. 75.3% of Viveon Health Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community believe in VHAQ or ZYBT? Viveon Health Acquisition and Zhengye Biotechnology both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformViveon Health AcquisitionN/AN/AZhengye BiotechnologyN/AN/A Does the media prefer VHAQ or ZYBT? In the previous week, Zhengye Biotechnology had 1 more articles in the media than Viveon Health Acquisition. MarketBeat recorded 1 mentions for Zhengye Biotechnology and 0 mentions for Viveon Health Acquisition. Viveon Health Acquisition's average media sentiment score of 0.00 equaled Zhengye Biotechnology'saverage media sentiment score. Company Overall Sentiment Viveon Health Acquisition Neutral Zhengye Biotechnology Neutral SummaryViveon Health Acquisition and Zhengye Biotechnology tied by winning 2 of the 4 factors compared between the two stocks. Get Viveon Health Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for VHAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VHAQ vs. The Competition Export to ExcelMetricViveon Health AcquisitionPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$56.60M$6.22B$5.21B$19.94BDividend YieldN/A2.94%5.13%3.71%P/E RatioN/A9.8789.3441.41Price / SalesN/A309.211,240.0416.25Price / CashN/A61.4443.7519.84Price / BookN/A6.055.315.76Net Income-$610,000.00$154.90M$122.54M$993.25M7 Day PerformanceN/A-0.32%0.59%3.12%1 Month PerformanceN/A0.43%2.55%4.75%1 Year Performance-10.87%3.08%25.29%18.83% Viveon Health Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VHAQViveon Health AcquisitionN/A$10.00flatN/AN/A$56.56MN/A0.002High Trading VolumeZYBTZhengye BiotechnologyN/A$4.73+0.9%N/AN/A$223.10M$189.75M0.00N/AGOSSGossamer Bio4.4621 of 5 stars$0.96-3.8%$9.20+856.4%+10.6%$217.97MN/A-3.01180Positive NewsGap UpCADLCandel Therapeutics3.4112 of 5 stars$6.66-13.4%$19.00+185.3%+416.3%$216.32M$120,000.00-3.8560MOLNMolecular Partners0.1987 of 5 stars$5.36-7.8%N/A+17.4%$216.13M$7.84M-2.49180Gap DownFULCFulcrum Therapeutics2.0338 of 5 stars$3.96-0.5%$9.33+135.7%-42.8%$213.60M$2.81M-12.77100Positive NewsLRMRLarimar Therapeutics1.3894 of 5 stars$3.34+2.8%$20.43+511.6%-22.0%$213.13MN/A-2.9030Gap UpFDMT4D Molecular Therapeutics3.4754 of 5 stars$4.58-2.1%$38.56+741.8%-73.1%$211.73M$20.72M-1.61120Analyst ForecastACBAurora Cannabis0.214 of 5 stars$3.85-2.8%N/A-6.4%$211.29M$200.35M-5.071,073Short Interest ↑OCGNOcugen2.158 of 5 stars$0.71-0.7%$5.67+698.1%+38.7%$206.84M$6.04M-3.9480SOPHSOPHiA GENETICS2.96 of 5 stars$3.12+4.7%$7.40+137.2%-30.7%$203.99M$62.37M-2.86520News CoveragePositive News Related Companies and Tools Related Companies Zhengye Biotechnology Alternatives Gossamer Bio Alternatives Candel Therapeutics Alternatives Molecular Partners Alternatives Fulcrum Therapeutics Alternatives Larimar Therapeutics Alternatives 4D Molecular Therapeutics Alternatives Aurora Cannabis Alternatives Ocugen Alternatives SOPHiA GENETICS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:VHAQ) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveon Health Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveon Health Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VHAQ Stock Alerts